Howard Lutnick has been universally criticized by industry for his reported proposal to tax patent values and revenue share ...
The warning signs of an economy under pressure are all around, from mass layoffs to companies moving out of state, writes ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
ASHINGTON (Reuters) -Hundreds of thousands of U.S. federal workers have been ordered not to report to work, while others have ...
Q3 2025 Earnings Call November 5, 2025 10:00 AM ESTCompany ParticipantsDelbert RoseRyan Ezell - CEO, President ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
In an October 16 mayoral debate, Mamdani claimed that children in New York were going hungry. In fact, their biggest problem ...
What began as a system designed to make victims whole has become one in which financiers gamble on corporate risk aversion.
The US Food and Drug Administration (FDA) has approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
Multimetal producer Aurubis is highly sought after by investors this year. The MDax company, valued at around 5 billion euros ...
It has struggled to find enough nurses, therapists and maintenance staff. Trump’s immigration crackdown ... immigrants traditionally have contributed more than their share of patents, innovation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback